Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to bioreductive drugs. I. Tirapazamine - PubMed (original) (raw)

Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to bioreductive drugs. I. Tirapazamine

P L Olive. Br J Cancer. 1995 Mar.

Free PMC article

Abstract

The possibility of using tirapazamine (SR 4233) to identify hypoxic cells in multicell spheroids and murine tumours was examined by measuring tirapazamine-induced DNA damage to individual cells from multicell spheroids and SCCVII murine tumours. Fluorescence microscopy and image analysis were used to measure the extent of migration of DNA from individual cells embedded in agarose and exposed to an electric field. Using both the alkaline and neutral versions of the comet assay, at least 20 times more single-strand breaks were observed in cells from fully anoxic than fully oxic Chinese hamster V79 spheroids exposed to 30 microM tirapazamine, and about 10 times more single- than double-strand breaks were observed. Cells from spheroids containing about 50% radiobiologically hypoxic cells showed a pattern of tirapazamine breaks which translated to approximately 30% well-oxygenated in SCCVII tumors growing in C3H mice was also demonstrated. Cells close to tumour blood vessels showed less DNA damage by 20 mg kg-1 tirapazamine than cells distant from blood vessels. Rejoining of single-strand breaks was exponential, with a half-time of about 1 h under aerobic conditions, but rejoining half-time increased to 2 h for cells allowed to repair under anoxic conditions. While tirapazamine damage to DNA measured using the comet assay cannot provide a direct measure of hypoxic fraction, the degree of heterogeneity in DNA damage can be used to estimate the range and distribution of individual cell oxygen contents within spheroids and tumours.

PubMed Disclaimer

Cited by

Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia.
Olive PL, Durand RE, Raleigh JA, Luo C, Aquino-Parsons C. Olive PL, et al. Br J Cancer. 2000 Dec;83(11):1525-31. doi: 10.1054/bjoc.2000.1489. Br J Cancer. 2000. PMID: 11076663 Free PMC article.
Improved potency of the hypoxic cytotoxin tirapazamine by DNA-targeting.
Delahoussaye YM, Hay MP, Pruijn FB, Denny WA, Brown JM. Delahoussaye YM, et al. Biochem Pharmacol. 2003 Jun 1;65(11):1807-15. doi: 10.1016/s0006-2952(03)00199-0. Biochem Pharmacol. 2003. PMID: 12781332 Free PMC article.
Tirapazamine-induced DNA damage measured using the comet assay correlates with cytotoxicity towards hypoxic tumour cells in vitro.
Siim BG, van Zijl PL, Brown JM. Siim BG, et al. Br J Cancer. 1996 Apr;73(8):952-60. doi: 10.1038/bjc.1996.187. Br J Cancer. 1996. PMID: 8611431 Free PMC article.
Evaluation of a novel in vitro assay for assessing drug penetration into avascular regions of tumours.
Phillips RM, Loadman PM, Cronin BP. Phillips RM, et al. Br J Cancer. 1998 Jun;77(12):2112-9. doi: 10.1038/bjc.1998.355. Br J Cancer. 1998. PMID: 9649122 Free PMC article.
Radiologic differences between bone marrow stromal and hematopoietic progenitor cell lines from Fanconi Anemia (Fancd2(-/-)) mice.
Berhane H, Epperly MW, Goff J, Kalash R, Cao S, Franicola D, Zhang X, Shields D, Houghton F, Wang H, Wipf P, Parmar K, Greenberger JS. Berhane H, et al. Radiat Res. 2014 Jan;181(1):76-89. doi: 10.1667/RR13405.1. Epub 2014 Jan 7. Radiat Res. 2014. PMID: 24397476 Free PMC article.

References

1. Int J Radiat Biol Relat Stud Phys Chem Med. 1974 Oct;26(4):383-9 - PubMed
1. Radiother Oncol. 1994 Jul;32(1):37-46 - PubMed
1. Radiat Res. 1981 May;86(2):185-95 - PubMed
1. Biochem Biophys Res Commun. 1984 Aug 30;123(1):291-8 - PubMed
1. Int J Radiat Oncol Biol Phys. 1986 Jul;12(7):1239-42 - PubMed

Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to bioreductive drugs. I. Tirapazamine - PubMed (original) (raw)